SCHEMBL7023323

SCHEMBL7023323

CC(C)(C)OC(=O)NC1(C(=O)N(Cc2ccccc2)C2(C#N)CCNC2)CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CTSS P25774 8/20 0.42
CTSB P07858 5/20 0.42
CTSL P07711 4/20 0.42
AKT1 P31749 3/20 0.37
CTSK P43235 3/20 0.35
FAAH O00519 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA7 P43166 1/20 0.34
CA14 Q9ULX7 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GHSR Q92847 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419101 0.88 CTSS (0.53) CTSSCTSBCTSLCTSK
SCHEMBL6565010 0.77 CTSS (0.34) CTSSCTSBCTSLCTSK
SCHEMBL19742568 0.71 CTSL (0.52) CTSSCTSBCTSLAKT1CA12
SCHEMBL7420196 0.71 CTSS (0.36) CTSSCTSBCTSLCTSKKMT2A
SCHEMBL6567042 0.71 CTSS (0.35) CTSSCTSBCTSLCTSK
SCHEMBL7420191 0.70 SNCA (0.34) CTSSCTSBCTSLCTSK
SCHEMBL6371523 0.69 SNCA (0.33) CTSSCTSK
SCHEMBL7419245 0.69 SIGMAR1 (0.41) CTSSCTSBCTSLCTSK
SCHEMBL7417235 0.69 L3MBTL1 (0.35) KMT2AL3MBTL1
SCHEMBL7417228 0.68 CTSL (0.44) CTSSCTSBCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003529546-A 2003-10-07 JP claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP claimed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed